<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-2014-28-3-2</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-28-3-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Seizure Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epilepsy Comorbidities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0798-0131</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>John J.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Ann &#x0026; Robert H. Lurie Children&#x0027;s Hospital of Chicago, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1">
<label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>03</month>
<year>2014</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>31</day>
<month>10</month>
<year>2015</year>
</pub-date>
<volume>28</volume>
<issue>3</issue>
<fpage>18</fpage>
<lpage>19</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2014 The Author(s)</copyright-statement>
<copyright-year>2014</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/j.yebeh.2013.11.027" vol="31" page="127">
<article-title>Epilepsy and comorbidities &#x2013; What are we waiting for?</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Investigators at Children&#x0027;s Hospital of Pittsburgh, PA; UCLA; and Univ Wisconsin, Madison, WI, draw attention to the lack of attention to comorbidities in the treatment of epilepsy.</p>
</abstract>
<kwd-group>
<kwd>Psychiatric</kwd>
<kwd>Linguistic</kwd>
<kwd>ADHD-Inattentive Subtype</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Investigators at Children&#x0027;s Hospital of Pittsburgh, PA; UCLA; and Univ Wisconsin, Madison, WI, draw attention to the lack of attention to comorbidities in the treatment of epilepsy. Comorbidities include depression, anxiety disorders, ADHD, interictal psychosis, autism, and suicidal behavior. Despite studies that demonstrate the frequency of cognitive, psychiatric, linguistic, and social problems, the translation of research data to clinical practice is frequently hindered by limited access to critical cognitive and psychological evaluations and counseling. The NINDS Epilepsy Benchmarks and other national initiatives emphasize the need for comprehensive care for patients with epilepsy, yet there is a continuing lack of interest in support of these goals. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENTARY. ADHD is a common comorbidity of epilepsy, occurring in one of 5 children with epilepsy [<xref ref-type="bibr" rid="CIT0002">2</xref>]. Quality of life was impaired twofold in children with epilepsy complicated by ADHD-inattentive subtype (ADHD-I), and fourfold with ADHD-hyperactive-Impulsive subtype (ADHD-C) comorbidity, when compared to non-ADHD/epilepsy patients. Methylphenidate with AEDs may be beneficial in treatment of ADHD and AED refractory epilepsy [<xref ref-type="bibr" rid="CIT0003">3</xref>, <xref ref-type="bibr" rid="CIT0004">4</xref>].</p>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asato</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Caplan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hermann</surname>
<given-names>BP</given-names>
</name>
</person-group>
<article-title>Epilepsy and comorbidities &#x2013; What are we waiting for?</article-title>
<source>Epilepsy Behav</source>
<year>2014</year>
<month>Feb</month>
<volume>31</volume>
<fpage>127</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2013.11.027</pub-id>
<pub-id pub-id-type="pmid">24397916</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gross-Tsur</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Manor</surname>
<given-names>O</given-names>
</name>
<name>
<surname>van der Meere</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shalev</surname>
<given-names>RS</given-names>
</name>
</person-group>
<article-title>Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective?</article-title>
<source>J Pediatr</source>
<year>1997</year>
<month>Apr</month>
<volume>130</volume>
<issue>4</issue>
<fpage>670</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-3476(97)70258-0</pub-id>
<pub-id pub-id-type="pmid">9432523</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fosi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lax-Pericall</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Neville</surname>
<given-names>BG</given-names>
</name>
<name>
<surname>Aylett</surname>
<given-names>SE</given-names>
</name>
</person-group>
<article-title>Methylphenidate treatment of attention deficit hyperactivity disorder in young people with learning disability and difficult-to-treat epilepsy: evidence of clinical benefit</article-title>
<source>Epilepsia</source>
<year>2013</year>
<month>Dec</month>
<volume>54</volume>
<issue>12</issue>
<fpage>2071</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1111/epi.12399</pub-id>
<pub-id pub-id-type="pmid">24304474</pub-id>
</element-citation>
</ref>
<ref id="CIT0004">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millichap</surname>
<given-names>JG</given-names>
</name>
</person-group>
<article-title>Pediatr Neurol Briefs</article-title>
<year>2014</year>
<month>Feb</month>
<volume>28</volume>
<issue>2</issue>
<fpage>10</fpage>
<lpage>11</lpage>
</element-citation>
</ref>
</ref-list>
</back>
</article>
